Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M121,301Revenue (TTM) $M22,991Net Margin (%)33.6Altman Z-Score2.8
Enterprise Value $M117,812EPS (TTM) $10.3Operating Margin %42.6Piotroski F-Score8
P/E(ttm)16.1Beneish M-Score-2.7Pre-tax Margin (%)39.9Higher ROA y-yY
Price/Book4.110-y EBITDA Growth Rate %12.8Quick Ratio3.9Cash flow > EarningsY
Price/Sales5.45-y EBITDA Growth Rate %20.3Current Ratio4.1Lower Leverage y-yY
Price/Free Cash Flow13.1y-y EBITDA Growth Rate %14.3ROA % (ttm)10.2Higher Current Ratio y-yN
Dividend Yield %2.5PEG0.8ROE % (ttm)26.2Less Shares Outstanding y-yY
Payout Ratio %39.0Shares Outstanding M736ROIC % (ttm)29.7Gross Margin Increase y-yY

Gurus Latest Trades with AMGN

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

AMGN is held by these investors:

AMGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Such Annette LouiseVP, Finance and CAO 2016-08-02Sell3,000$174.59-5.54view
Balachandran MadhavanEVP, Operations 2016-05-04Sell30,000$154.127view
Harper Sean EEVP, Research & Development 2016-04-29Sell21,875$157.994.38view
BALTIMORE DAVIDDirector 2016-04-29Sell3,312$157.214.9view
Bradway Robert AChairman, CEO and President 2016-03-02Sell20,000$146.4812.58view
de Carbonnel FrancoisDirector 2015-08-31Sell5,000$153.847.2view
Hassan FredDirector 2015-08-19Buy3,010$166.63-1.03view
PELHAM JUDITH CDirector 2015-07-31Sell5,035$180.4-8.59view
Patton Cynthia MSVP & CCO 2015-06-02Sell4,530$157.065view
Balachandran MadhavanEVP, Operations 2015-05-07Sell21,750$157.874.46view

Press Releases about AMGN :

Quarterly/Annual Reports about AMGN:

    News about AMGN:

    Articles On GuruFocus.com
    Amgen's Humira Biosimilar Approved in Europe Mar 27 2017 
    6 Best Stocks for Value Investors This Week Mar 26 2017 
    Smead Value Fund 4th Quarter Shareholder Letter Mar 07 2017 
    Daniel Loeb Drops Pharma, Picks Up Rate-Sensitive Financials Feb 13 2017 
    GuruFocus Interview: Orbimed Guru Sam Isaly on Investing in New Era of Healthcare Feb 15 2017 
    How BioVie, Conatus and PhaseRX Tackle Liver Diseases Feb 08 2017 
    Daniel Loeb's Third Point Hedge Fund 4th Quarter Commentary Feb 02 2017 
    Calendar 4th Quarter Shareholder Letter From Marty Whitman's Third Avenue Value Fund Feb 01 2017 
    6 Stocks Trading Below Peter Lynch Value Jan 26 2017 
    AbbVie Increases Price of Humira Jan 23 2017 

    More From Other Websites
    Amgen's Humira Biosimilar Approved in Europe Mar 27 2017
    Short Interest Pulls Back in Major Biotechs Mar 27 2017
    Google life sciences spinoff soaks up huge space (video) Mar 24 2017
    Amgen's (AMGN) Humira Biosimilar Receives Approval in EU Mar 24 2017
    The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Alliance, General... Mar 24 2017
    Amgen Secures EU Approval for Anti-Inflammatory Drug Mar 24 2017
    European Commission Approves AMGEVITA™ (Biosimilar Adalimumab) For The Treatment Of Certain... Mar 23 2017
    Stock Research Reports for Amgen, Berkshire & Walgreens Mar 23 2017
    Regeneron, Sanofi Look To Crush Amgen, And Rivals Say They Can Mar 23 2017
    Biotechs Back in the Doghouse After Failed Rally Mar 23 2017
    Biotech giant plans $25M Tampa investment, 450 jobs Mar 22 2017
    Zacks Investment Ideas feature highlights: Nasdaq Biotechnology Index, Gilead, Valeant Pharma,... Mar 22 2017
    Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results Mar 22 2017
    Sanofi and Regeneron Sue Amgen over Eczema Drug Mar 21 2017
    Sanofi-Genzyme files preemptive legal strike to protect eczema drug Mar 21 2017
    4 Health Care Charts Signaling Buys: Pfizer, Amgen Included Mar 21 2017
    Sanofi, Regeneron sue Amgen to protect eczema drug from patent claims Mar 21 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)